Study of PX-866 and Docetaxel in Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01204099
Recruitment Status : Completed
First Posted : September 17, 2010
Last Update Posted : June 12, 2015
Information provided by (Responsible Party):
Cascadian Therapeutics Inc.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2013
  Actual Study Completion Date : February 2014
  Certification/Extension First Submitted : April 30, 2015